Dr. Agarwal IPO: IPO Size, Open date, GMP Updates
Dr. Agarwal IPO is raising ₹3027.26 crore through The issue is a combination of fresh issue of 0.75 crore shares aggregating to ₹300.00 crores and offer for sale of 6.78 crore shares aggregating to ₹2,727.26 crores. Dr. Agarwal IPO estimated listing price is ₹462 (cap price + today’s GMP).The expected percentage gain/loss per share is 14.93% as on 24th of Jan 2025. IPO will open for application on 29th Jan, 2025, and close on 31st Jan, 2025. The allotment will be finalized on 3rd Feb, 2025, with the shares tentatively listed on the BSE and NSE on 5th Jan, 2025.
The price band for the IPO is ₹382 to ₹402 per share with ₹1 per share face value. Retail investors can apply for a minimum lot size of 35 shares, requiring an investment of ₹14,070. Small Non-Institutional Investors (sNII) need a minimum of 15 lots (525 shares), amounting to ₹2,11,050, while large Non-Institutional Investors (bNII) must apply for 72 lots (2,520 shares), amounting to ₹10,13,040.
| IPO Open Date | Wednesday, January 29, 2025 |
| IPO Close Date | Friday, January 31, 2025 |
| Basis of Allotment | Monday, February 3, 2025 |
| Initiation of Refunds | Tuesday, February 4, 2025 |
| Credit of Shares to Demat | Tuesday, February 4, 2025 |
| Listing Date | Wednesday, February 5, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on January 31, 2025 |
Company Financial Report
Company revenue ₹1,376.45 crores in 2024 against ₹1,031.49 crore in 2023. Company profit ₹95.05 crores in 2024 against Profit of ₹103.23 crores in 2023. Company current financial year Q2 revenue is ₹837.94 and profit is ₹39.56.
Amount ₹ in Crores
| Period Ended | Revenue | Expense | Profit After Tax | Assets |
| 2022 | ₹713.78 | ₹657.02 | ₹43.16 | ₹1,026.13 |
| 2023 | ₹1,031.49 | ₹947.90 | ₹103.23 | ₹1,825.17 |
| 2024 | ₹1,376.45 | ₹1,235.88 | ₹95.05 | ₹2,752.82 |
| September 2024 | ₹837.94 | ₹777.59 | ₹39.56 | ₹3,393.41 |
About Dr. Agarwal’s Health Care Limited
Dr. Agarwal’s Eye Hospital is a chain of eye specialty hospitals in India, headquartered at Chennai. Started by Jaiveer Agarwal with his wife Tahira Agarwal as an eye care centre in Chennai, it has grown to 180+ centres across India and 15 centres overseas. Incorporated in 2010, Dr. Agarwal’s Health Care Limited offers a comprehensive range of eye care services, including cataract and refractive surgeries, consultations, diagnoses, non-surgical treatments, and the sale of optical products, contact lenses, accessories, and eye care-related pharmaceutical items.
Website: https://dragarwals.co.in/
Dr. Agarwal’s Health Care IPO Registrar
KFin Technologies Limited
Phone: 04067162222, 04079611000
Email: ahcl.ipo@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/
